Sign in
The Real-World Characteristics and Outcomes of Newly Diagnosed Myeloma Patients Ineligible for Clinical Trials
Abstract   Peer reviewed

The Real-World Characteristics and Outcomes of Newly Diagnosed Myeloma Patients Ineligible for Clinical Trials

Mark Fiala, James Dukeman, Keith Stockerl-Goldstein, Michael Tomasson, Tanya Wildes and Ravi Vij
Clinical lymphoma, myeloma and leukemia, Vol.17(1), pp.e55-e56
02/2017
DOI: 10.1016/j.clml.2017.03.101

View Online

Details